COSMOS "constitution" set
This article was originally published in The Rose Sheet
Executive Summary
European organizations BDIH from Germany, Cosmebio and Ecocert from France, ICEA from Italy and the U.K.'s Soil Association have formed a non-profit association to develop the COSMOS standard as an internationally recognized standard for organic and natural cosmetics. The COSMOS-standard AISBL will "ensure cooperation between all parties for the benefits of consumers," BDIH's Harald Dittmar says in a release. The constitution for the standard was incorporated by members on May 4. The association will further develop the COSMOS standard, oversee and authorize certification, as well as "evolve continually in the direction of more organic ingredients and environmental improvement," according to May 18 release. Cosmebio's Betty Santonnat was appointed secretary general for daily management of the non-profit. The association will be open to new member organizations once it receives a royal decree from Belgian authorities. The COSMOS organic standard was released in June of last year (1"The Rose Sheet" June 15, 2009, In Brief)
You may also be interested in...
Cosmos organic standard
Final version of the Cosmos organic standard has been released, Organic Monitor reports June 11. The product of extended negotiations between six European organic certification agencies - including the Soil Association, BDIH and Ecocert - Cosmos will open itself to the certification process in September. Organic Monitor notes that Cosmos will have to compete against other organic standards for the attention of industry and consumers, including NaTrue in Europe and, in the U.S., NSF International's "Made with Organic" standard, among others on the way such as the Organic and Sustainable Industry Standards (OASIS). Organic Monitor will offer classes to address the differences among the standards and the major technical and formulation issues raised by them, it says; the next class is to be held July 8 in London, with classes following in North America and Asia later in the year
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.